Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1964 1
1965 1
1968 1
1981 4
1982 4
1983 7
1984 9
1985 11
1986 11
1987 13
1988 13
1989 11
1990 14
1991 23
1992 25
1993 28
1994 32
1995 29
1996 30
1997 32
1998 25
1999 30
2000 29
2001 58
2002 57
2003 87
2004 114
2005 117
2006 154
2007 179
2008 179
2009 231
2010 260
2011 316
2012 412
2013 502
2014 572
2015 650
2016 660
2017 703
2018 771
2019 891
2020 1138
2021 1314
2022 1524
2023 1617
2024 1805
2025 37

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,258 results

Results by year

Filters applied: . Clear all
Page 1
Emerging pharmacotherapy for inflammatory bowel diseases.
Luo H, Cao G, Luo C, Tan D, Vong CT, Xu Y, Wang S, Lu H, Wang Y, Jing W. Luo H, et al. Pharmacol Res. 2022 Apr;178:106146. doi: 10.1016/j.phrs.2022.106146. Epub 2022 Feb 25. Pharmacol Res. 2022. PMID: 35227890 Review.
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial.
Ren S, Chen J, Xu X, Jiang T, Cheng Y, Chen G, Pan Y, Fang Y, Wang Q, Huang Y, Yao W, Wang R, Li X, Zhang W, Zhang Y, Hu S, Guo R, Shi J, Wang Z, Cao P, Wang D, Fang J, Luo H, Geng Y, Xing C, Lv D, Zhang Y, Yu J, Cang S, Yang Z, Shi W, Zou J, Zhou C; CameL-sq Study Group. Ren S, et al. Among authors: luo h. J Thorac Oncol. 2022 Apr;17(4):544-557. doi: 10.1016/j.jtho.2021.11.018. Epub 2021 Dec 16. J Thorac Oncol. 2022. PMID: 34923163 Free article. Clinical Trial.
Nanocellulose-Based Antibacterial Materials.
Li J, Cha R, Mou K, Zhao X, Long K, Luo H, Zhou F, Jiang X. Li J, et al. Among authors: luo h. Adv Healthc Mater. 2018 Oct;7(20):e1800334. doi: 10.1002/adhm.201800334. Epub 2018 Jun 19. Adv Healthc Mater. 2018. PMID: 29923342 Review.
Integration of Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanisms of Zhuanggu Busui Formula Against Osteoporosis.
Zhang H, Zhou C, Zhang Z, Yao S, Bian Y, Fu F, Luo H, Li Y, Yan S, Ge Y, Chen Y, Zhan K, Yue M, Du W, Tian K, Jin H, Li X, Tong P, Ruan H, Wu C. Zhang H, et al. Among authors: luo h. Front Endocrinol (Lausanne). 2022 Jan 28;12:841668. doi: 10.3389/fendo.2021.841668. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35154014 Free PMC article.
Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.
Li Z, Peng M, Chen P, Liu C, Hu A, Zhang Y, Peng J, Liu J, Li Y, Li W, Zhu W, Guan D, Zhang Y, Chen H, Li J, Fan D, Huang K, Lin F, Zhang Z, Guo Z, Luo H, He X, Zhu Y, Li L, Huang B, Cai W, Gu L, Lu Y, Deng K, Yan L, Chen S. Li Z, et al. Among authors: luo h. Cell Metab. 2022 Mar 1;34(3):424-440.e7. doi: 10.1016/j.cmet.2022.01.008. Epub 2022 Feb 11. Cell Metab. 2022. PMID: 35150639 Free PMC article.
13,258 results
You have reached the last available page of results. Please see the User Guide for more information.